About Event
8th Edition WORLD CANCER CONGRESS - 2024 Organized by Arjyopa Healthcare on 9TH & 10TH MARCH, 2024 at JNU CONVENTION CENTRE, NEW DELHI, INDIA
THEME: “EXPLORING NEW HORIZONS IN ONCOLOGY AND CANCER RESEARCH”
Note:
Early Bird Registration Closes 27th February 2023,
1st Phase Abstract Submission Closes: 17th November 2023
Registration
Attendee Types | Super Early UP TO 27 Feb 2023 | Early bird UP TO 17 Aug 2023 | Regular UP TO 17 Feb 2024 | Spot UP TO 9 Mar 2024 |
|---|---|---|---|---|
GENERAL CATEGORY (Access to All Sessions, Access to Sponsors Area, Tea/Coffee break during the conference, Handbook & Conference Kit, A free paper abstract(For Speakers), Lunch during the conference, Certificate of Presentation, Certificate of Attendance) | INR 4999 | INR 5999 | INR 6999 | INR 7999 |
RESEARCH FELLOWS (Access to All Sessions, Access to Sponsors Area, Tea/Coffee break during the conference, Handbook & Conference Kit(Congress Bag, Final Program - in Print, Book of Abstracts), Lunch during the conference, Certificate of Presentation, Certificate of Attendance) | INR 4999 | INR 5999 | INR 6999 | INR 7999 |
STUDENTS(UG, PG) Access to All Sessions Access to Sponsors Area Tea/Coffee break during the conference Handbook & Conference Kit(Congress Bag, Final Program - in Print, Book of Abstracts) Lunch during the conference Certificate of Presentation Certificate of Attendance | INR 3999 | INR 4999 | INR 5999 | INR 6999 |
INDUSTRY PARTICIPANTS Access to All Sessions Access to Sponsors Area Tea/Coffee break during the conference Handbook & Conference Kit(Congress Bag, Final Program - in Print, Book of Abstracts) Lunch during the conference Certificate of Attendance | INR 10999 | INR 11999 | INR 12999 | INR 13999 |
Foreign Registration
Attendee Types | Super Early UP TO 27 Feb 2023 | Early bird UP TO 17 Aug 2023 | Regular UP TO 17 Feb 2024 | Spot UP TO 9 Mar 2024 |
|---|---|---|---|---|
General Category(International) - General Category/Medical Practioner/HOD/Dean/Faculty/Professor/Asso. Professor/Asst. Professor | USD 399 | USD 599 | USD 699 | USD 799 |
STUDENT & RESEARCH FELLOWS Access to All Sessions Access to Sponsors Area Tea/Coffee break during the conference Handbook & Conference Kit(Congress Bag, Final Program - in Print, Book of Abstracts) Lunch during the conference Certificate of Attendance | USD 299 | USD 499 | USD 599 | USD 699 |
Schedule
Day 1
Day 2
8:00 AM
-
9:00 AM
REGISTRATIONS OPENS
9:00 AM
-
9:30 AM
INAGURATION OF THE CONFERENCE
9:30 AM
-
10:50 AM
KEYNOTE ADDRESS(ORGAN DEFINED CANCER)
The Session will explore the different types of organ cancer such as Brest Cancer, Lung Cancer, Cervical Cancer, Urologic Cancers, Pancreatic cancer, Pediatric cancer, Prostate Cancer, Bladder cancer, Bone cancer, Brain cancer. The Session will also cover the latest advancement in the treatment of organ defined cancer, its prevention and also the future scope.
10:50 AM
-
11:00 AM
NETWORKING BREAK
11:00 AM
-
1:00 PM
CANCER BIOMARKERS & NOVEL THERAPEUTICS
Cancer biomarkers are emerging as important tools for disease diagnosis, prediction and prognosis
The Session will focus on:
- Cancer genomics and biomarkers for breast cancer, prostate cancer and more.
- The design of novel compounds and conjugates for high selective targeting in treatment.
- Synthetic and medicinal chemistry of anticancer agents.
- Mathematical and statistical modeling of cancer data.
- Oncolytic viruses as novel cancer therapeutics.
1:00 PM
-
2:00 PM
LUNCH & NETWORKING BREAK
2:00 PM
-
4:00 PM
CLINICALS TRIALS IN ONCOLOGY
Although less than 5% of patients with cancer are enrolled in clinical trials, such trials represent an important link between basic cancer research and clinical practice. Clinical trials serve as the foundation for evidence-based medicine by addressing specific clinical questions that may lead to improvements in current clinical practice.
This session will basically focus on finding a new ways to:
- Treat cancer
- Find and diagnose cancer
- Prevent cancer
- Manage symptoms of cancer and side effects from its treatment.
- Different Phases in clinical Trials.
- Biological, Clinical, and Psychosocial Correlates at the Interface of Cancer and Aging Research.
4:00 PM
-
4:10 PM
NETWORKING BREAK
4:10 PM
-
6:30 PM
HIGH IMPACT PREVENTION AND RISK FACTOR REDUCTION
The Session will explore primary prevention, including health promotion, examples of best practice in new evidence-based prevention strategies, and vaccines. Exposure to environmental risk factors unhealthy environments will be included, as well as new areas of development in policy, programme management, communications, and education.
Organizer
Arjyopa Healthcare, India
Kolkata, West Bengal, India